Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taro Takami

Showing results (141-150 of 175) with videos related to

Pageof 18
Sort By:
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 20, 2022
Diagnostic criteria for acute-on-chronic liver failure and related disease conditions in JapanSatoshi Mochida, Nobuaki Nakayama, Shuji Terai, et al.
Cancer Medicine|February 14, 2025
Survival Analysis of 4 Different Age Groups of Pancreatic Ductal Adenocarcinoma After Radical Resection From Retrospective Multi-Center Analysis (YPB-003)Hiroto Matsui, Tatsuya Ioka, Toru Kawaoka, et al.
The Journal of Experimental Medicine|September 19, 2023
Lysosomal cholesterol overload in macrophages promotes liver fibrosis in a mouse model of NASHMichiko Itoh, Atsushi Tamura, Sayaka Kanai, et al.
Journal of Clinical Medicine|February 26, 2025
Real-World Setting of Efficacy and Safety of 3 Years of Rifaximin Administration in Japanese Patients with Hepatic Encephalopathy: A Multicenter Retrospective StudyHideto Kawaratani, Tadashi Namisaki, Yasuteru Kondo, et al.
Oncology|October 16, 2022
CA19-9 in Combination with Methylated HOXA1 and SST Is Useful to Diagnose Stage I Pancreatic CancerYutaka Suehiro, Shigeyuki Suenaga, Yuki Kunimune, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 9, 2026
Post-to Pretreatment Ratio of Serum CXCL10 Level Predicts Short-Term Liver Function Outcome in Compensated and Decompensated Cirrhotic Patients Due to Chronic Hepatitis C Virus Infection After Direct-Acting Antiviral TherapyTakanori Suzuki, Kentaro Matsuura, Yuki Tahata, et al.
Cancers|March 29, 2020
Early Predictors of Objective Response in Patients with Hepatocellular Carcinoma Undergoing Lenvatinib TreatmentIssei Saeki, Takahiro Yamasaki, Satoyoshi Yamashita, et al.
Clinical and Translational Gastroenterology|May 30, 2020
Fecal DNA Testing of TWIST1 Methylation Identifies Patients With Advanced Colorectal Adenoma Missed by Fecal Immunochemical Test for HemoglobinYutaka Suehiro, Shinichi Hashimoto, Atsushi Goto, et al.
Cancers|June 10, 2023
Early Prediction of Response Focused on Tumor Markers in Atezolizumab plus Bevacizumab Therapy for Hepatocellular CarcinomaNorikazu Tanabe, Issei Saeki, Yuki Aibe, et al.
Journal of Clinical Medicine|February 15, 2022
Cyclin D1 Binding Protein 1 Responds to DNA Damage through the ATM-CHK2 PathwayYusuke Niwa, Kenya Kamimura, Kohei Ogawa, et al.
Pageof 18

Showing results (141-150 of 175) with videos related to

Sort By:
Pageof 18
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 20, 2022
Diagnostic criteria for acute-on-chronic liver failure and related disease conditions in JapanSatoshi Mochida, Nobuaki Nakayama, Shuji Terai, et al.
Cancer Medicine|February 14, 2025
Survival Analysis of 4 Different Age Groups of Pancreatic Ductal Adenocarcinoma After Radical Resection From Retrospective Multi-Center Analysis (YPB-003)Hiroto Matsui, Tatsuya Ioka, Toru Kawaoka, et al.
The Journal of Experimental Medicine|September 19, 2023
Lysosomal cholesterol overload in macrophages promotes liver fibrosis in a mouse model of NASHMichiko Itoh, Atsushi Tamura, Sayaka Kanai, et al.
Journal of Clinical Medicine|February 26, 2025
Real-World Setting of Efficacy and Safety of 3 Years of Rifaximin Administration in Japanese Patients with Hepatic Encephalopathy: A Multicenter Retrospective StudyHideto Kawaratani, Tadashi Namisaki, Yasuteru Kondo, et al.
Oncology|October 16, 2022
CA19-9 in Combination with Methylated HOXA1 and SST Is Useful to Diagnose Stage I Pancreatic CancerYutaka Suehiro, Shigeyuki Suenaga, Yuki Kunimune, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 9, 2026
Post-to Pretreatment Ratio of Serum CXCL10 Level Predicts Short-Term Liver Function Outcome in Compensated and Decompensated Cirrhotic Patients Due to Chronic Hepatitis C Virus Infection After Direct-Acting Antiviral TherapyTakanori Suzuki, Kentaro Matsuura, Yuki Tahata, et al.
Cancers|March 29, 2020
Early Predictors of Objective Response in Patients with Hepatocellular Carcinoma Undergoing Lenvatinib TreatmentIssei Saeki, Takahiro Yamasaki, Satoyoshi Yamashita, et al.
Clinical and Translational Gastroenterology|May 30, 2020
Fecal DNA Testing of TWIST1 Methylation Identifies Patients With Advanced Colorectal Adenoma Missed by Fecal Immunochemical Test for HemoglobinYutaka Suehiro, Shinichi Hashimoto, Atsushi Goto, et al.
Cancers|June 10, 2023
Early Prediction of Response Focused on Tumor Markers in Atezolizumab plus Bevacizumab Therapy for Hepatocellular CarcinomaNorikazu Tanabe, Issei Saeki, Yuki Aibe, et al.
Journal of Clinical Medicine|February 15, 2022
Cyclin D1 Binding Protein 1 Responds to DNA Damage through the ATM-CHK2 PathwayYusuke Niwa, Kenya Kamimura, Kohei Ogawa, et al.
Pageof 18